Molecule Details
| InChIKey | ROKOFZNQCIIJMI-UHFFFAOYSA-N |
|---|---|
| Compound Name | SB-216995 |
| Canonical SMILES | Fc1ccc(-c2ncn(CC3CC3)c2-c2ccncc2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.21 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB08522 |
|---|---|
| Drug Name | 4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE |
| CAS Number | nan |
| Groups | experimental |
| ATC Codes | nan |
| Description | nan |
Cross-references: BindingDB: 15237 CHEMBL96741 ChemSpider: 4984 PDB: SB6 PubChem:5171 PubChem:99444993 ZINC: ZINC000002047872
Target Activities (4)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | inhibitor | targets |